Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Bristol-Myers Squibb and Tsinghua University Announce Collaboration to Accelerate Early Research into Potential Therapies for Autoimmune Diseases and Cancer
Wednesday, July 25, 2018BristolMyers Squibb Company and Tsinghua University have entered into a collaboration to discover therapeutic agents against novel targets for autoimmune diseases and cancers The collaboration brings together BristolMyers Squibb and Tsinghua Universi...
AbbVie Receives U.S. FDA Approval of ORILISSA™ (elagolix) for the Management of Moderate to Severe Pain Associated with Endometriosis
Wednesday, July 25, 2018AbbVie a researchbased global biopharmaceutical company in cooperation with Neurocrine Biosciences Inc announced that the US Food and Drug Administration FDA approved ORILISSA elagolix the first and only oral gonadotropinreleasing hormone GnRH antag...
Adamis Pharmaceuticals Adds Sublingual Erectile Dysfunction Product Candidate to its Pipeline
Tuesday, July 24, 2018Adamis Pharmaceuticals Corporation announced today that it has been conducting preIND development work for a fastdissolving sublingual tablet containing tadalafil Adamis intends to submit an investigational new drug IND application to the US Food and...
Cambrex to Acquire Halo Pharma, Adding Drug Development and Finished Dosage Capabilities to Global API Manufacturing Network
Tuesday, July 24, 2018Cambrex Corporation a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients APIs today announced it has entered into a definitive agreement to acquire Halo Pharma Halo a leading dosage form Contract Developmen...
Luye Pharma Well Positioned for CNS Market with the Approval of A New Indication for Seroquel XR in China
Monday, July 23, 2018Luye Pharma Group has announced that its Central Nervous System CNS drug Seroquel XR Quetiapine Fumarate XR has received approval from the official Chinese medical authorities for a new indication in the treatment of depression arising from bipolar d...
Enzyvant Announces Collaboration with PerkinElmer to Enable Diagnostic Testing for Farber Disease
Saturday, July 21, 2018Enzyvant a biopharmaceutical company focused on developing innovative treatments for people living with rare diseases today announced that it has formed a collaboration with PerkinElmer Genomics a global genomic testing company PerkinElmer Genomic...
Koutif Therapeutics Confirms Clinical Candidate Drug
Saturday, July 21, 2018Koutif Therapeutics today announced that KT which has been selected as its lead compound has reached clinical candidate status for the treatment of inflammatory bowel disease including ulcerative colitis and Crohns Disease after successfully completi...
An innovative drug for Alzheimer's disease from China at the end of Phase 3 clinical trials
Friday, July 20, 2018Shanghai Green Valley Pharmaceutical Co Ltd today announced that Phase trials for Sodium Oligomannurarate GV capsules used in mild to mediumsized cases Alzheimers disease reached the first endpoint Randomized doubleblind clinical trials with plac...
Yisheng Biopharma Announces Opening of New Business Divisions in Cambodia, Expanding Presence within Southeast Asia
Friday, July 20, 2018Yisheng Biopharma Co Ltd a biopharmaceutical company focusing on research development manufacturing sales and marketing of immunological biologics and vaccines today announced the grand opening of Anderson Biotech Company Limited and Royal OncoCare H...
PolyU - Axis Therapeutics Joint Center for Immunotherapy Launched to Develop Innovative Cancer Treatments
Thursday, July 19, 2018The Hong Kong Polytechnic University PolyU will join forces with Axis Therapeutics a newly established joint venture by two global biopharmaceutical companies Athenex Inc and Xiangxue Pharmaceutical to foster the research and development of translat...
